CClinicalTrials.gg
CompletedNCT07221916SMRPUpdated Apr 22, 2026

Stryker's Surgeon iD Mandible Reconstruction Plates: A Retrospective Post Market Follow Up

An observational study in Mandible Fracture and Mandibular Reconstruction, sponsored by Stryker Craniomaxillofacial. Completed at 2 sites in 2 countries. Per ClinicalTrials.gov, last updated 2026-04-22.

Sponsored by Stryker Craniomaxillofacial · Observational

Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
70
Sex
All
01

Study summary

A retrospective post market follow up to confirm safety and performance of Stryker's Surgeon iD Plates (SMRP) medical device. The study is performed to confirm the product's performance and safety by systematically collecting clinical data on its use.

Read the detailed description

This is a retrospective non-interventional post-market follow up aiming at confirming safety and performance of Stryker's Surgeon iD Mandible Recon Plate when used in the clinical setting. This study will include patients who have previously undergone a surgical procedure involving the Study Device, with surgical outcomes evaluated retrospectively.

Based on a non-inferiority study power calculation a minimum of 27 patients will be enrolled in the study. Additional patients may be enrolled up to 80 subjects depending on site enrolment rate and patient availability. Up to 3 investigational sites within the United States and one in the EU will participate in this study. The primary outcome parameter evaluating successful reconstruction of the mandible without the need for unplanned revision surgery will be assessed at all available follow-up timepoints for included patients.

02

Conditions studied

  • Mandible Fracture
  • Mandibular Reconstruction

Browse trials for

03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Eligible patients will be identified as having had a surgical procedure involving the Subject Device.

Inclusion criteria

  1. Patients who underwent primary or secondary mandibular reconstruction using a Stryker Surgeon iD Plate implant as per routine clinical practice.
  2. Patients for whom data on the primary outcome variable is available.

Exclusion criteria

Exclusion Criteria:

  1. Patients with active local infections at the time of surgery.
  2. Patients with known metal allergies and/or foreign body sensitivity at the time of surgery.
  3. Potentially non-compliant patients who were unwilling or incapable of following post-operative care instructions.
  4. Patients with inadequate bone quantity or quality necessary for plate fixation or stabilization at the time of surgery
04

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
70 participants (actual)
Patient registry
No

Interventions

  • DeviceMandibular Reconstruction

    Mandibular Reconstruction or mandibular fracture fixation using a Surgeon iD Mandible Reconstruction Plate (referred to as Surgeon iD Plates).

    Also known as: Mandibular Fracture Fixation

05

What researchers measure

Primary outcomes

  1. Rate of successful reconstruction of the mandible without the need for unplanned revision surgery compared to benchmark devices in scientific literature.

    Rate of unplanned revision surgery determined by reviewing adverse events in patient medical charts after surgery. Used to document whether an unplanned revision surgery was required or not for each patient.

    Time frame: Data collected at a single time point per patient in the course of 12 months

Secondary outcomes

  1. Infection rate

    Determined by adverse events reported from patient medical charts.

    Time frame: Data collected at time points from patient medical charts in the course of 12 months.

  2. Intraoperative complications

    Determined by adverse events reported from patient medical charts.

    Time frame: Data collected at a single time point per patient in the course of 12 months.

  3. Postoperative complications

    Determined by adverse events reported from patient medical charts.

    Time frame: Data collected at time points per patient in the course of 12 months.

  4. Any known adverse events

    Determined by adverse events reported from patient medical charts.

    Time frame: Data collected at time points per patient in the course of 12 months.

  5. Rate of Plate failure

    Determined by adverse events reported from patient medical charts.

    Time frame: Data collected at time points per patient in the course of 12 months.

  6. Operating room (OR) time

    Time patients are operated (hh:mm)

    Time frame: Data collected at a single time point per patient in the course of 12 months.

  7. Time to return to solid food/normal diet

    Time for patient to return to solid food/normal diet post operation (dd)

    Time frame: Data collected at a single time point per patient in the course of 12 months.

  8. Rate of satisfactory occlusion achieved with orthodontic treatment.

    Assessed by review of individual patient medical records that document the rate of satisfactory occlusion achieved with orthodontic treatment.

    Time frame: Data collected at time points per patient in the course of 12 months.

  9. Hospitalization time: ICU and normal ward

    Time the patient was hospitalized post procedure (dd:hh)

    Time frame: Data collected at a single time point per patient in the course of 12 months.

  10. Short-form-12-health-survey-questionnaire (if available)

    Short-form-12-health-survey-Questionnaire (Scale of 0-100. Scores above 50 indicate a better-than-average health-related quality of life, while scores below 50 suggest below-average health).

    Time frame: Data collected at time points per patient in the course of 12 months.

  11. Ischemia time

    Ischemia time (dd:hh)

    Time frame: Data collected at a single time point per patient in the course of 12 months.

  12. EuroQol-5 Domain Questionnaire (if available)

    A descriptive system and a visual analogue scale (VAS). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each with three to five levels of severity. The VAS provides a subjective rating of overall health on a scale from 0 to 100 (higher is better)).

    Time frame: Data collected at time points per patient in the course of 12 months.

  13. Facial Appearance, Quality of Life, and Satisfaction Questionnaire (if available)

    40 independently functioning scales and checklists. Multiple independent scales, each with a 0-100 score, where higher scores indicate better outcomes. Scores are calculated by summing responses on a 4-point Likert scale (e.g., strongly disagree to strongly agree), which are then converted to the 0-100 range. Each scale measures a specific aspect of facial appearance, quality of life, or adverse effects and cannot be summed into a single total score.

    Time frame: Data collected at time points per patient in the course of 12 months.

Other outcomes

  1. Patient age

    Age (years)

    Time frame: Data collected at a single time point per patient in the course of 12 months.

  2. Primary indication for the surgery / diagnosis

    Diagnosis collected from patient medical charts.

    Time frame: Data collected at a single time point per patient in the course of 12 months.

  3. Follow-up time

    Post operative follow up time for patients within standard of care. Reported in patient medical charts during hospital follow up visit.

    Time frame: Data collected at a single time point per patient in the course of 12 months.

  4. Surgical approach

    Surgical approach taken for the procedure. Including: transoral; transbuccal; submandibular; preauricular; other

    Time frame: Data collected at a single time point per patient in the course of 16 months.

  5. Rate of osteotomy

    Cases where osteotomy (e.g. BSSO) was performed. Instrumentation used to perform the osteotomy.

    Time frame: Data collected at time points per patient in the course of 12 months.

  6. Frequency of Maxilla-mandibular fixation

    Number of maxillo-mandibular fixation procedures (number per patient).

    Time frame: Data collected at time points per patient in the course of 12 months.

  7. Relevant Medical conditions

    Descriptive data of any underlying medical conditions and medications recorded in patient medical charts that may be related to the device or primary outcome (qualitative measure).

    Time frame: Data collected at time points per patient in the course of 12 months.

  8. Primary/secondary reconstruction performed

    Type of reconstruction procedure performed (e.g. immediately or after an initial surgery).

    Time frame: Data collected at time points point per patient in the course of 12 months

  9. Localization of the defect

    Area to treated by the device: mandibular ramus; mandibular body; mandibular condyle; parasymphysis; paramedian; other

    Time frame: Data collected at time points point per patient in the course of 12 months.

  10. Flap used

    Type of flap used: vascularized fibula flap, vascularized scapula flap, vascularized iliac crest flap, avascularized fibula flap, avascularized scapula flap, avascularized iliac crest flap, others

    Time frame: Data collected at a single time point per patient in the course of 12 months.

  11. Radiation

    Exposure of patient to radiation therapy within 12 months around the surgery date recorded in patient medical charts. Radiation therapy performed on the anatomical area treated with the device. Any postoperative radiation therapy recorded in patient medical charts.

    Time frame: Data collected at time points per patient in the course of 12 months.

  12. Dental reconstruction in a single stage surgery

    Data for dental reconstruction collected from patient medical charts.

    Time frame: Data collected at time points per patient in the course of 12 months.

  13. Sterilization method used

    Sterilization method used for the device.

    Time frame: Data collected at a single time point per patient in the course of 12 months.

  14. Fixation system used

    System used to fix the device during the procedure. Stryker Universal Mandible System; other Types and number of screws

    Time frame: Data collected at a single time point per patient in the course of 12 months.

  15. Plate types

    2.0 or 2.8 plates used, hemi or full reconstruction plate used

    Time frame: Data collected at a single time point per patient in the course of 12 months.

  16. Gender

    Responses: Male, Female, undifferentiated, unknown

    Time frame: Data collected at a single time point per patient in the course of 12 months

  17. Patient height

    Height (cm, feet, inches)

    Time frame: Data collected at a single time point per patient in the course of 12 months.

  18. Patient weight

    Weight (kg, lb)

    Time frame: Data collected at a single time point per patient in the course of 12 months.

  19. Year smoking was stopped

    Year smoking was stopped (YYYY)

    Time frame: Data collected at time points per patient in the course of 12 months.

  20. Smoking frequency

    The frequency of exposure to smoking during periods of smoking (average number of cigarettes per day).

    Time frame: Data collected at time points per patient in the course of 12 month

  21. Smoking duration

    Duration of smoking (pack years)

    Time frame: Data collected at time points per patient in the course of 12 month

  22. Years of active smoking

    Total number of years active smoker (YY)

    Time frame: Data collected at time points per patient in the course of 12 month

06

Study locations

2 sites
  • UCSF Otolaryngology Head and Neck Surgery
    San Francisco, California 94143, United States
  • Heinrich-Braun-Klinikum gGmbH
    Zwickau, 08060, Germany
07

References and documents

08

Registry details

Key details

Study ID
NCT07221916
Lead sponsor
Stryker Craniomaxillofacial
Responsible party
Sponsor
First posted
Oct 28, 2025
Start date
Dec 1, 2024
Primary completion
Feb 27, 2026
Completion
Feb 27, 2026
Last update
Apr 22, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion